PROVIDER PROFILE · NPI 1962584318

Coleen AcevedoCRNP

Nurse PractitionerWest Reading, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

323

Unique beneficiaries

—

Total services

555

Distinct HCPCS

Medicare payment

$27K

Peer benchmark

Total Medicare services vs. 7,939 Nurse Practitioner providers in PA — top quintile (cohort median 235).

PRESCRIBING · PART D · 2024

Total Rx claims

1,911

Beneficiaries

—

Total drug cost

$788K

Distinct drugs

Brand share

87.1%

Top prescribed drugs

Insulin Glargine,hum.Rec.Anlog257 claims

Pen Needle, Diabetic153 claims

Insulin Aspart152 claims

Semaglutide134 claims

Metformin Hcl103 claims

QUALITY · MIPS · 2024

Final MIPS score

88.1

Quality

77.2

Cost

79.0

Improvement activities

40.0

Promoting interop.

98.0

Payment adjustment

0.55%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Coleen Acevedo's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Ilan Gabriely Endocrinology · Wyomissing, PA	36	94
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	24	45
John Serrian Cardiology · West Reading, PA	13	25
YEBOAH, KORDOR	12	31
William Santoro Addiction Medicine · West Reading, PA	12	26
Earl Hope Interventional Cardiology · West Reading, PA	11	28

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history